Crossing MT5-MMP-deficient mice with the 5xFAD AD mouse model produced bigenic mice that had reduced Aβ plaque deposition and reduced soluble Aβ and soluble APP C-terminal fragments (CTFs) within the brain and improved performance on a behavioral learning task [67,68,74]. Here, APP is linked to Alzheimer disease.